Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFREmily M. Ploeg, Wijnand Helfrich|Journal for ImmunoTherapy of Cancer|2023Cited by 13
A Novel Bispecific Antibody for EpCAM-Directed Inhibition of the CD73/Adenosine Immune Checkpoint in Ovarian CancerEmily M. Ploeg, Wijnand Helfrich|Cancers|2023Cited by 5